Allogeneic Hematopoietic Stem Cell Transplantation With Bevacizumab for Advanced Solid Tumor
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Ovarian Cancer
Interventions: DRUG: Bevacizumab|PROCEDURE: Allogeneic Hematopoietic Stem Cell Transplantation|DRUG: Fludarabine|DRUG: Melphalan|DRUG: Thymoglobulin
Sponsor: M.D. Anderson Cancer Center